TORONTO, ON – Food Allergy Canada welcomed today’s announcement from Health Canada regarding the confirmed temporary supply of AUVI-Q® epinephrine auto-injectors from kaléo.
The unprecedented shipment of this life-saving medication is an important step towards alleviating the pressure families living with food allergies are facing and is a measure Food Allergy Canada has been advocating for.
“This is positive news for Canadians with food allergies and we commend Health Canada for taking the necessary action to secure these devices,” said Jennifer Gerdts, Executive Director of Food Allergy Canada.
Since January of this year, Food Allergy Canada has been working closely with Health Canada, alternate providers, and other key stakeholders to help expedite the possibility of having a second supplier in the market.
Now that temporary supply has been secured in the short-term, Food Allergy Canada will continue its advocacy to ensure there is always more than one supplier of this life-saving medication in Canada…
Lesen Sie weiter auf: Statement from Food Allergy Canada on Health Canada securing temporary access to new epinephrine auto-injectors
Quelle: Food Allergy Canada
Titelbild/Grafik by Food Allergy Canada
Kommentare und FragenMöchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von Food Allergy Canada